Patent · US Active

Methods of treating disorders using CSF1R inhibitors

US11103507B2 · kind B2 · utility

36Cited by

31References

30Claims

0Family size

Assignee

Deciphera Pharmaceuticals, LLC · US

Inventors

Daniel L. Flynn · Lawrence, US
Bryan D. Smith · Madison, US
Rodrigo Ruiz Soto · Waltham, US
Keisuke Kuida · Waltham, US

Key dates

Filing date	Dec 23, 2019
Grant date	Aug 31, 2021
Priority date	—
Expiry date	Feb 3, 2040

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described herein are methods of treating cancers and other tumors related to the decreased proliferation, the depletion, or the repolarization of tumor-associated macrophages (TAMs) and treatment of associated disorders, including tenosynovial giant cell tumor (TGCT) and diffuse-type tenosynovial giant cell tumor (DTGCT).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.